Status	Stage
New Updated	Protocol Review

• Acupuncture and acupressure for premenstrual syndrome
• Acupuncture and assisted reproductive technology
• Acupuncture for dysmenorrhoea
• Acupuncture for menopausal hot flushes
• Acupuncture for pain in endometriosis
• Acupuncture for polycystic ovarian syndrome
• Acupuncture for uterine fibroids
• Add-back therapy with GnRH analogues for uterine fibroids
• Adhesion prevention agents for gynaecological surgery: an overview of Cochrane reviews
• Advanced sperm selection techniques for assisted reproduction
• Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility
• Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
• Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility
• Anti-TNF-α treatment for pelvic pain associated with endometriosis
• Antibiotic prophylaxis for elective hysterectomy
• Antibiotics prior to or at the time of embryo transfer in ART
• Antidepressants for polycystic ovary syndrome
• Antifibrinolytics for heavy menstrual bleeding
• Antioxidants for male subfertility
• Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer)
• Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome
• Aromatase inhibitors for uterine fibroids
• Aspirin for in vitro fertilisation
• Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI))
• Assisted reproductive technologies for male subfertility
• Assisted reproductive technology: an overview of Cochrane Reviews
• Autologous platelet-rich plasma for assisted reproduction
• Barrier agents for adhesion prevention after gynaecological surgery
• Behavioural interventions for dysmenorrhoea
• Beta2-adrenoceptor agonists for dysmenorrhoea
• Bioidentical hormones for women with vasomotor symptoms
• Black cohosh (<I>Cimicifuga</I> spp.) for menopausal symptoms
• Blood biomarkers for the non-invasive diagnosis of endometriosis
• Brief co-incubation of sperm and oocytes for in vitro fertilization techniques
• Chinese herbal medicine for endometriosis
• Chinese herbal medicine for menopausal symptoms
• Chinese herbal medicine for premenstrual syndrome
• Chinese herbal medicine for primary dysmenorrhoea
• Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
• Chinese herbal medicine in the treatment of ectopic pregnancy
• Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology
• Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome
• Clomiphene citrate for unexplained subfertility in women
• Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome
• Combination of the non-invasive tests for the diagnosis of endometriosis
• Combined hormonal contraceptives for heavy menstrual bleeding
• Combined oral contraceptive pill for primary dysmenorrhoea
• Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis
• Culture media for human pre-implantation embryos in assisted reproductive technology cycles
• Cycle regimens for frozen-thawed embryo transfer
• Cyclical progestogens for heavy menstrual bleeding
• Cyproterone acetate for hirsutism
• Danazol for heavy menstrual bleeding
• Danazol for pelvic pain associated with endometriosis
• Danazol for unexplained subfertility
• Danazol for uterine fibroids
• Day 5 versus day 3 embryo biopsy for preimplantation genetic testing for monogenic/single gene defects
• Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection
• Decision aids for the management of menopausal symptoms
• Dehydroepiandrosterone for women in the peri- or postmenopausal phase
• Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles
• Dietary supplements for dysmenorrhoea
• Dopamine agonists for preventing ovarian hyperstimulation syndrome
• Double versus single intrauterine insemination (IUI) in stimulated cycles for subfertile couples
• Early versus delayed oral feeding after major gynaecologic surgery
• Embryo freezing for preventing ovarian hyperstimulation syndrome
• Endometrial biomarkers for the non-invasive diagnosis of endometriosis
• Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction
• Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination
• Endometrial injury in women attempting to conceive following sexual intercourse or intrauterine insemination: a collaborative individual participant data meta-analysis (IPD-MA)
• Endometrial injury in women undergoing in vitro fertilisation (IVF)
• Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
• Endometrial resection and ablation techniques for heavy menstrual bleeding
• Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding
• Endometriosis: an overview of Cochrane Reviews
• Excisional surgery versus ablative surgery for ovarian endometrioma
• Exercise for dysmenorrhoea
• Exercise for vasomotor menopausal symptoms
• Fluid and pharmacological agents for adhesion prevention after gynaecological surgery
• Follicular flushing during oocyte retrieval in assisted reproductive techniques
• Fresh versus frozen embryo transfers in assisted reproduction
• Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI
• GM-CSF (granulocyte macrophage colony-stimulating factor) supplementation in culture media for women undergoing assisted reproduction
• GnRH agonists for uterine fibroids
• Gonadotrophin antagonists for pain associated with endometriosis
• Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density
• Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
• Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
• Gonadotrophins for idiopathic male factor subfertility
• Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS)
• Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction
• Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology
• Gonadotropin-releasing hormone analogues for endometriosis
• Granulocyte-colony stimulating factor administration for subfertile women undergoing assisted reproduction
• Growth hormone for in vitro fertilisation (IVF)
• Heparin for assisted reproduction
• Herbal preparations for uterine fibroids
• High-intensity focused ultrasound for symptomatic uterine fibroids
• Hormonal treatment for uterine adenomyosis
• Hormone therapy for endometriosis and surgical menopause
• Hormone therapy for sexual function in perimenopausal and postmenopausal women
• Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency
• Hormone therapy in postmenopausal women and risk of endometrial hyperplasia
• Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation
• Hyaluronic acid in embryo transfer media for assisted reproductive technologies
• Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women
• Hysterectomy with opportunistic salpingectomy versus hysterectomy alone
• Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities
• Imaging modalities for the non-invasive diagnosis of endometriosis
• Immune therapies for women with history of failed implantation undergoing IVF treatment
• In vitro fertilisation for unexplained subfertility
• In vitro fertilisation versus tubal reanastomosis (sterilisation reversal) for subfertility after tubal sterilisation
• In-bag manual versus uncontained power morcellation for laparoscopic myomectomy
• Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)
• Inositol for subfertile women with polycystic ovary syndrome
• Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
• Interventions commonly available during pandemics for heavy menstrual bleeding: an overview of Cochrane Reviews
• Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)
• Interventions for fertility preservation in women with cancer undergoing chemotherapy
• Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis
• Interventions for improving reproductive outcomes in women with recurrent implantation failure undergoing assisted reproductive techniques
• Interventions for non-tubal ectopic pregnancy
• Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews
• Interventions for tubal ectopic pregnancy
• Interventions for unexplained infertility: a systematic review and network meta-analysis
• Interventions for uterine fibroids: an overview of Cochrane Reviews
• Interventions for women with endometrioma prior to assisted reproductive technology
• Interventions to reduce haemorrhage during myomectomy for fibroids
• Interventions to reduce shoulder pain following gynaecological laparoscopic procedures
• Intra-uterine insemination for unexplained subfertility
• Intra-uterine insemination versus timed intercourse or expectant management for cervical hostility in subfertile couples
• Intracytoplasmic sperm injection versus conventional in vitro fertilisation in couples with males presenting with normal total sperm count and motility
• Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction
• Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
• Intrauterine insemination versus intracervical insemination in donor sperm treatment
• Laparoscopic entry techniques
• Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome
• Laparoscopic surgery for endometriosis
• Laparoscopy for the management of acute lower abdominal pain in women of childbearing age
• Laparoscopy versus laparotomy for benign ovarian tumour
• Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
• Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery
• Levonorgestrel-releasing intrauterine system for endometrial hyperplasia
• Lifestyle changes in women with polycystic ovary syndrome
• Local oestrogen for vaginal atrophy in postmenopausal women
• Long versus short course treatment with metformin and clomiphene citrate for ovulation induction in women with PCOS
• Long-acting FSH versus daily FSH for women undergoing assisted reproduction
• Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis
• Long-term hormone therapy for perimenopausal and postmenopausal women
• Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis
• Low oxygen concentrations for embryo culture in assisted reproductive technologies
• Luteal phase support for assisted reproduction cycles
• Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse
• Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies
• Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome
• Metformin for endometrial hyperplasia
• Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
• Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
• Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome
• Microwave therapy for cervical ectropion
• Mifepristone for uterine fibroids
• Minimally invasive surgical techniques versus open myomectomy for uterine fibroids
• Minimally invasive versus open surgery for reversal of tubal sterilization
• Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI)
• Natural cycle in vitro fertilisation (IVF) for subfertile couples
• Nifedipine for primary dysmenorrhoea
• Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome
• Non-hormonal therapy for hot flushes in postmenopausal women
• Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding
• Non-surgical interventions for the management of chronic pelvic pain
• Nonsteroidal anti-inflammatory drugs for assisted reproductive technology
• Nonsteroidal anti-inflammatory drugs for dysmenorrhoea
• Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis
• Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection
• Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
• Oral and intrauterine progestogens for atypical endometrial hyperplasia
• Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques
• Oral contraceptives containing drospirenone for premenstrual syndrome
• Oral contraceptives for pain associated with endometriosis
• Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation
• Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
• Oral versus injectable ovulation induction agents for unexplained subfertility
• Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility
• Ovarian surgery for symptom relief in women with polycystic ovary syndrome
• Ovulation suppression for endometriosis for women with subfertility
• Ovulation triggers in anovulatory women undergoing ovulation induction
• Oxytocin antagonists for assisted reproduction
• Pain relief for outpatient hysteroscopy
• Pain relief for women undergoing oocyte retrieval for assisted reproduction
• Pain relief in hysterosalpingography
• Pentoxifylline for the treatment of endometriosis-associated pain and infertility  
• Peri-implantation glucocorticoid administration for assisted reproductive technology cycles
• Perioperative interventions in pelvic organ prolapse surgery
• Pharmacological and non-pharmacological strategies for obese women with subfertility
• Pharmacological interventions for jet lag 
• Phytoestrogens for menopausal vasomotor symptoms
• Post-embryo transfer interventions for assisted reproduction technology cycles
• Postoperative procedures for improving fertility following pelvic reproductive surgery
• Pre- and postsurgical medical therapy for endometriosis surgery
• Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding
• Preconception lifestyle advice for people with infertility
• Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation
• Preoperative ripening of the cervix before operative hysteroscopy
• Progestagens and anti-progestagens for pain associated with endometriosis
• Progesterone for premenstrual syndrome
• Progesterone receptor modulators for endometriosis
• Progestogen-releasing intrauterine systems for heavy menstrual bleeding
• Progestogens for hot flushes
• Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle
• Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy)
• Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation
• Prophylactic antibiotics for transcervical intrauterine procedures
• Psychological and educational interventions for subfertile men and women
• Pulsatile gonadotrophin releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome
• Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles
• Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles
• Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles
• Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction
• Relaxation for perimenopausal and postmenopausal symptoms
• Screening hysteroscopy in subfertile women and women undergoing assisted reproduction
• Selective estrogen receptor modulators (SERMs) for uterine leiomyomas
• Selective oestrogen receptor modulators (SERMs) for endometriosis
• Selective progesterone receptor modulators (SPRMs) for uterine fibroids
• Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
• Semen preparation techniques for intrauterine insemination
• Septum resection for women of reproductive age with a septate uterus
• Short-term and long-term effects of tibolone in postmenopausal women
• Slow freeze versus vitrification for embryo cryopreservation
• Soft versus firm catheters for intrauterine insemination
• Soft versus firm embryo transfer catheters for assisted reproductive technology
• Spinal manipulation for dysmenorrhoea
• Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
• Statins for women with polycystic ovary syndrome not actively trying to conceive
• Surgery and minimally invasive treatments for uterine fibroids
• Surgery for tubal infertility
• Surgery for women with anterior compartment prolapse
• Surgery for women with apical vaginal prolapse
• Surgery for women with pelvic organ prolapse with or without stress urinary incontinence
• Surgery for women with posterior compartment prolapse
• Surgery versus medical therapy for heavy menstrual bleeding
• Surgical approach to hysterectomy for benign gynaecological disease
• Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea
• Surgical intervention versus expectant management for endometrial polyps in subfertile women
• Surgical interventions for the management of chronic pelvic pain in women
• Surgical or radiological treatment for varicoceles in subfertile men
• Surgical treatment for tubal disease in women due to undergo in vitro fertilisation
• Surgical treatment of fibroids for subfertility
• Synchronised approach for intrauterine insemination in subfertile couples
• Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction
• Techniques for pelvic surgery in subfertility
• Techniques for preparation prior to embryo transfer
• Techniques for surgical retrieval of sperm prior to intra-cytoplasmic sperm injection (ICSI) for azoospermia
• Temperature of embryo culture for assisted reproduction
• Testosterone for peri and postmenopausal women
• Three-dimensional saline infusion sonography compared to two-dimensional saline infusion sonography for the diagnosis of focal intracavitary lesions
• Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism
• Time-lapse systems for embryo incubation and assessment in assisted reproduction
• Timed intercourse for couples trying to conceive
• Total versus subtotal hysterectomy for benign gynaecological conditions
• Transcutaneous electrical nerve stimulation (TENS) for pain control in women with primary dysmenorrhoea
• Transcutaneous electrical nerve stimulation for primary dysmenorrhoea
• Transvaginal mesh or grafts or native tissue repair for vaginal prolapse
• Trocar types in laparoscopy
• Tubal flushing for subfertility
• Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women
• Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women
• Urinary biomarkers for the non-invasive diagnosis of endometriosis
• Uterine artery embolization for symptomatic uterine fibroids
• Uterine distension media for outpatient hysteroscopy
• Vaginal energy-based devices for vulvovaginal dryness
• Vasodilators for women undergoing fertility treatmentUpdated
• Visual tubal patency tests for tubal occlusion and hydrosalpinx
• Vitrification versus slow freezing for women undergoing oocyte cryopreservation
• Volume expanders for the prevention of ovarian hyperstimulation syndrome
• Oocyte activation for women following intracytoplasmic sperm injection (ICSI)
• Vitamins and minerals for subfertility in women
• What are the benefits and risks of medications given before surgery to remove non-cancerous growths in the womb (uterine fibroids)?Updated
• What is the best therapy for women who produce too many eggs when having fertility treatment?
• Which gonadotropins are the best choice to stimulate ovulation in women with polycystic ovary syndrome (PCOS)Updated

• PELVIC PAIN (37)
  • PAINFUL MENSTRUATION (EXCEPT WHEN CAUSED BY SPECIFIC PATHOLOGY) (15)
    • Medical Therapies (4)
      • Analgesics (0)
      • Antispasmodics (1)
        • Nifedipine for primary dysmenorrhoea
      • Nonsteroidal anti-inflammatory drugs (1)
        • Nonsteroidal anti-inflammatory drugs for dysmenorrhoea
      • Oral contraceptive pill (1)
        • Combined oral contraceptive pill for primary dysmenorrhoea
      • Progestogens (0)
      • Vasodilators (1)
        • Beta2-adrenoceptor agonists for dysmenorrhoea
    • Surgery (2)
      • Presacral neurectomy (1)
        • Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea
      • Laparoscopic uterine/uteroscral nerve ablation (1)
        • Surgical interruption of pelvic nerve pathways for primary and secondary dysmenorrhoea
    • Psychological Interventions (1)
      • Behavioural interventions for dysmenorrhoea
    • Transcutaneous electrical nerve stimulation (2)
      • Transcutaneous electrical nerve stimulation (TENS) for pain control in women with primary dysmenorrhoea
      • Transcutaneous electrical nerve stimulation for primary dysmenorrhoea
    • Alternative therapies (6)
      • Acupuncture (2)
        • Acupuncture for dysmenorrhoea
        • Transcutaneous electrical nerve stimulation for primary dysmenorrhoea
      • Spinal manipulation (1)
        • Spinal manipulation for dysmenorrhoea
      • Herbal/Dietary Supplements (2)
        • Chinese herbal medicine for primary dysmenorrhoea
        • Dietary supplements for dysmenorrhoea
      • Exercise (1)
        • Exercise for dysmenorrhoea
  • ENDOMETRIOSIS/ADENOMYOSIS (20)
    • Complementary therapies (2)
      • Acupuncture for pain in endometriosis
      • Chinese herbal medicine for endometriosis
    • Medical Therapies (14)
      • Danazol (1)
        • Danazol for pelvic pain associated with endometriosis
      • Gestrinone (0)
      • Gonadotrophin releasing hormone (4)
        • Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density
        • Gonadotrophin-releasing hormone analogues for pain associated with endometriosis
        • Gonadotropin-releasing hormone analogues for endometriosis
        • Gonadotrophin antagonists for pain associated with endometriosis
      • Hormone replacement therapy post pelvic clearance (surgical menopause) (0)
      • Nonsteroidal anti-inflammatory drugs (1)
        • Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis
      • Pre- and post- operative medical treatment (4)
        • Anti-TNF-α treatment for pelvic pain associated with endometriosis
        • Pentoxifylline for the treatment of endometriosis-associated pain and infertility  
        • Pre- and postsurgical medical therapy for endometriosis surgery
        • Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery
      • Progestogens (2)
        • Progestagens and anti-progestagens for pain associated with endometriosis
        • Progesterone receptor modulators for endometriosis
      • Oral contraceptive pill (1)
        • Oral contraceptives for pain associated with endometriosis
      • Selective estrogen receptor modulators (SERMs) (1)
        • Selective oestrogen receptor modulators (SERMs) for endometriosis
    • Surgery (3)
      • Drainage of endometriomas (0)
      • Hysterectomy (with or without bilateral salpingo-oophorectomy) (0)
      • Laparoscopic techniques - laser, diathermy (2)
        • Laparoscopic surgery for endometriosis
        • Excisional surgery versus ablative surgery for ovarian endometrioma
      • Laparoscopic uterine/uterosacral nerve ablation (1)
        • Surgical interventions for the management of chronic pelvic pain in women
      • Presacral neurectomy (0)
    • Overview (1)
      • Endometriosis: an overview of Cochrane Reviews
  • PELVIC VENOUS CONGESTION (0)
    • Medical Therapies (0)
      • Gonadotrophin releasing hormones (0)
      • Progestagens (0)
      • Other hormonal/chemical agents (0)
      • Vasoconstrictors (0)
    • Surgery (0)
    • Psychological Interventions (0)
      • Psychotherapy (0)
  • OTHER CHRONIC PELVIC PAIN (UNSPECIFIED BUT EXCLUDING PATHOLOGY) (2)
    • Medical Therapies (0)
      • Antidepressants (0)
      • Local anaesthetic (0)
      • Nonsteroidal anti-inflammatory drugs (0)
      • Oral contraceptive pill (0)
    • Psychological Interventions (0)
      • Counselling (0)
      • Photographic reinforcement (0)
    • All (2)
      • Laparoscopy for the management of acute lower abdominal pain in women of childbearing age
      • Non-surgical interventions for the management of chronic pelvic pain
  • OVARIAN REMNANT SYNDROME (0)
  • RESIDUAL OVARY SYNDROME (0)
• DISORDERS OF MENSTRUAL CYCLING / OLIGO-AMENORRHOEA IN ASSOCIATION WITH: (14)
  • POLYCYSTIC OVARIES (11)
    • Medical Therapies (9)
      • Antiandrogens (5)
        • Dopamine agonists for preventing ovarian hyperstimulation syndrome
        • Chinese herbal medicine for subfertile women with polycystic ovarian syndrome
        • Lifestyle changes in women with polycystic ovary syndrome
        • Antidepressants for polycystic ovary syndrome
        • Statins for women with polycystic ovary syndrome not actively trying to conceive
      • Gonadotrophin releasing hormones (0)
      • Oral contraceptive pill (0)
      • Progestogens (0)
      • Retinoids (0)
      • Insulin-sensitising drugs (4)
        • Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
        • Long versus short course treatment with metformin and clomiphene citrate for ovulation induction in women with PCOS
        • Metformin for endometrial hyperplasia
        • Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome
    • Surgery (2)
      • Wedge biopsy (1)
        • Ovarian surgery for symptom relief in women with polycystic ovary syndrome
      • Ovarian drilling (1)
        • Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women
  • ELEVATED PROLACTIN LEVELS (0)
    • Medical Therapies (0)
      • Bromocriptine (0)
      • Cabergoline (0)
    • Surgery (0)
  • WEIGHT-RELATED AMENORRHOEA (0)
    • Medical Therapies (0)
      • Antidepressants (0)
      • Hormone replacement therapy (0)
      • Oral contraceptive pill (0)
  • FUNCTIONAL OVARIAN CYSTS (0)
    • Medical Therapies (0)
      • Gonadotrophin releasing hormones (0)
      • Oral contraceptive pill (0)
      • Other hormones (0)
    • Surgery (0)
      • Drainage (0)
  • IRREGULAR MENSTRUAL BLEEDING (OLIGO-AMENORRHOEA, AMENORRHOEA) (1)
    • Progestogens with or without oestrogen for irregular uterine bleeding associated with anovulation
  • OTHER ENDOCRINE DISORDERS (E.G. CONGENITAL ADRENAL HYPERPLASIA) (2)
    • Aromatase inhibitors for uterine fibroids
    • Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy)
• HIRSUTISM AND RELATED ACNE (4)
  • MEDICAL THERAPIES (4)
    • Antiandrogens (2)
      • Cyproterone acetate for hirsutism
      • Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
    • Benzodiazepines (0)
    • Cimetidine (0)
    • Dopamine agonists (bromocriptine) (0)
    • Gonadotrophin releasing hormones (0)
    • Insulin-sensitising drugs (1)
      • Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome
    • Oral contraceptive pill (1)
      • Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome
    • Progestagens (0)
    • Pyridostinine (0)
    • Retinoids (0)
  • SURGERY (0)
    • Wedge biopsy (0)
    • Ovarian drilling/diathermy (0)
• EXCESSIVE MENSTRUAL BLEEDING (35)
  • IDIOPATHIC EXCESSIVE MENSTRUAL BLEEDING (17)
    • Investigation (1)
      • Endometrial sampling techniques/dilatation and curettage (0)
      • Ultrasound of endometrium (0)
      • Hysteroscopy (1)
        • Three-dimensional saline infusion sonography compared to two-dimensional saline infusion sonography for the diagnosis of focal intracavitary lesions
    • Medical Therapies (10)
      • Antifibrinolytic agents (1)
        • Antifibrinolytics for heavy menstrual bleeding
      • Danazol (1)
        • Danazol for heavy menstrual bleeding
      • Hormone replacement therapy (0)
      • Levonorgestrel IUCD (4)
        • Levonorgestrel-releasing intrauterine system for endometrial hyperplasia
        • Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen
        • Oral and intrauterine progestogens for atypical endometrial hyperplasia
        • Progestogen-releasing intrauterine systems for heavy menstrual bleeding
      • Nonsteroidal anti-inflammatory drugs (1)
        • Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding
      • Oral contraceptive pill (1)
        • Combined hormonal contraceptives for heavy menstrual bleeding
      • Other hormones (0)
      • Progestagens (2)
        • Cyclical progestogens for heavy menstrual bleeding
        • Progestogen-releasing intrauterine systems for heavy menstrual bleeding
    • Surgery (6)
      • Dilatation and curettage (0)
      • Endometrial ablation or resection (all methods) (4)
        • Endometrial resection and ablation techniques for heavy menstrual bleeding
        • Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding
        • Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding
        • Surgery versus medical therapy for heavy menstrual bleeding
      • Radiofrequency and microwave techniques (0)
      • Hysterectomy (2)
        • Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding
        • Surgery versus medical therapy for heavy menstrual bleeding
    • Psychological (0)
      • Counselling (0)
  • Overview (2)
    • Interventions commonly available during pandemics for heavy menstrual bleeding: an overview of Cochrane Reviews
    • Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis
  • TREATMENT OF FIBROIDS (15)
    • Medical Therapies (9)
      • Danazol (1)
        • Danazol for uterine fibroids
      • Gestrinone (0)
      • Gonadotrophin releasing hormones (3)
        • Add-back therapy with GnRH analogues for uterine fibroids
        • GnRH agonists for uterine fibroids
        • What are the benefits and risks of medications given before surgery to remove non-cancerous growths in the womb (uterine fibroids)?Updated
      • Nonsteroidal anti-inflammatory drugs (0)
      • Progestogens (0)
      • Other hormones (3)
        • Selective progesterone receptor modulators (SPRMs) for uterine fibroids
        • Mifepristone for uterine fibroids
        • Selective estrogen receptor modulators (SERMs) for uterine leiomyomas
      • Herbal preparations (2)
        • Acupuncture for uterine fibroids
        • Herbal preparations for uterine fibroids
    • Overview (1)
      • Interventions for uterine fibroids: an overview of Cochrane Reviews
    • Surgery (5)
      • Dilatation and curettage (0)
      • Endoscopic techniques (0)
      • HIFU (1)
        • High-intensity focused ultrasound for symptomatic uterine fibroids
      • Hysterectomy (0)
      • Myomectomy (3)
        • In-bag manual versus uncontained power morcellation for laparoscopic myomectomy
        • Interventions to reduce haemorrhage during myomectomy for fibroids
        • Minimally invasive surgical techniques versus open myomectomy for uterine fibroids
      • UAE (1)
        • Uterine artery embolization for symptomatic uterine fibroids
  • ADENOMYOSIS (1)
    • Medical therapies (1)
      • Hormonal treatment for uterine adenomyosis
• CLIMACTERIC/MENOPAUSE (22)
  • PREVENTION AND TREATMENT OF SHORT TERM PROBLEMS (12)
    • Medical Treatments (7)
      • Antidepressants (0)
      • Antifibrinolytics (0)
      • Antihypertensives (0)
      • Clonidine (0)
      • Hormone replacement therapy (5)
        • Bioidentical hormones for women with vasomotor symptoms
        • Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
        • Hormone therapy in postmenopausal women and risk of endometrial hyperplasia
        • Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
        • Local oestrogen for vaginal atrophy in postmenopausal women
      • Naloxone (0)
      • Oral contraceptive pill (0)
      • Essential fatty acids (e.g. evening primrose oil) (0)
      • Other hormones (1)
        • Testosterone for peri and postmenopausal women
      • Non-hormonal therapy (1)
        • Non-hormonal therapy for hot flushes in postmenopausal women
    • Psychological Interventions (0)
    • Exercise (1)
      • Exercise for vasomotor menopausal symptoms
    • Nutrition/Diet (1)
      • Phytoestrogens (1)
        • Phytoestrogens for menopausal vasomotor symptoms
    • Alternative Therapies (3)
      • Chinese herbs (1)
        • Chinese herbal medicine for menopausal symptoms
      • Acupuncture (1)
        • Acupuncture for menopausal hot flushes
      • Other (1)
        • Vaginal energy-based devices for vulvovaginal dryness
  • PREVENTION AND TREATMENT OF MEDIUM TERM PROBLEMS (2)
    • Medical Treatments (2)
      • Hormone replacement therapy (2)
        • Progestogens for hot flushes
        • Relaxation for perimenopausal and postmenopausal symptoms
  • PREVENTION AND TREATMENT OF LONG TERM PROBLEMS (8)
    • Black cohosh (<I>Cimicifuga</I> spp.) for menopausal symptoms
    • Decision aids for the management of menopausal symptoms
    • Dehydroepiandrosterone for women in the peri- or postmenopausal phase
    • Hormone therapy for sexual function in perimenopausal and postmenopausal women
    • Hormone therapy for endometriosis and surgical menopause
    • Long-term hormone therapy for perimenopausal and postmenopausal women
    • Short-term and long-term effects of tibolone in postmenopausal women
    • Hormone therapy for uterine and endometrial development in women with premature ovarian insufficiency
• PREMENSTRUAL SYNDROME (includes cyclical mood swings and premenstrual exacerbation of symptoms) (7)
  • PREVENTION AND TREATMENT (7)
    • Medical Treatment (5)
      • Anorexiants (0)
      • Bromocriptine (0)
      • Clonidine (0)
      • Danazol (0)
      • Diuretics (0)
      • Dopamine (0)
      • Essential fatty acids (e.g. evening primrose oil) (0)
      • Gonadotrophin releasing hormones (1)
        • Gonadotropin-releasing hormone (GnRH) analogues for premenstrual syndrome (PMS)
      • Hormones (2)
        • Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome
        • Progesterone for premenstrual syndrome
      • Minerals, supplements, or herbal treatments (e.g. magnesium) (0)
      • Nonsteroidal anti-inflammatory drugs (0)
      • Oral contraceptive pill (1)
        • Oral contraceptives containing drospirenone for premenstrual syndrome
      • Psychotropic drugs (e.g. antidepressants, anti-anxiety agents, tranquillisers) (0)
      • Vitamins (0)
      • Other medications (1)
        • Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder
    • Surgery (0)
      • Hysterectomy (with and without bilateral salpingo-oophorectomy) (0)
    • Psychological Interventions (0)
      • Relaxation (0)
    • Exercise (0)
    • Nutrition (0)
    • Alternative therapies (2)
      • Acupuncture (1)
        • Acupuncture and acupressure for premenstrual syndrome
      • Biofeedback (0)
      • Chinese herbal medicine (1)
        • Chinese herbal medicine for premenstrual syndrome
      • Reflexology (0)
• GYNAECOLOGICAL SURGERY (excluding malignant conditions but including complications after surgery) (20)
  • MEDICAL THERAPIES (2)
    • Antibiotics (2)
      • Antibiotic prophylaxis for elective hysterectomy
      • Prophylactic antibiotics for transcervical intrauterine procedures
    • Anticoagulants (0)
    • Catheterisation (0)
    • Local anaesthetics (0)
    • Nonsteroidal anti-inflammatory drugs (0)
  • SURGICAL INTERVENTIONS (1)
    • Adhesion barriers (e.g. Interceed) (1)
      • Anti-adhesion therapy following operative hysteroscopy for treatment of female subfertility
    • Diathermy (0)
    • Intravenous fluids (0)
    • Suture techniques (0)
    • Wound closures (0)
  • SURGICAL TECHNIQUES (15)
    • Types of hysterectomy (5)
      • Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women
      • Interventions for non-tubal ectopic pregnancy
      • Total versus subtotal hysterectomy for benign gynaecological conditions
      • Surgical approach to hysterectomy for benign gynaecological disease
      • Hysterectomy with opportunistic salpingectomy versus hysterectomy alone
    • Minimally invasive surgery (5)
      • Trocar types in laparoscopy
      • Interventions for non-tubal ectopic pregnancy
      • Laparoscopic entry techniques
      • Laparoscopy versus laparotomy for benign ovarian tumour
      • Microwave therapy for cervical ectropion
    • Outpatient hysteroscopy (5)
      • Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities
      • Pain relief for outpatient hysteroscopy
      • Preoperative ripening of the cervix before operative hysteroscopy
      • Screening hysteroscopy in subfertile women and women undergoing assisted reproduction
      • Uterine distension media for outpatient hysteroscopy
  • POST-OPERATIVE COMPLICATIONS FOLLOWING GYNAECOLOGICAL SURGERY (e.g. urinary retention, thromboembolism) (2)
    • Medical Therapies (0)
      • Antibiotics (0)
      • Anticoagulants (0)
    • Other (2)
      • Early versus delayed oral feeding after major gynaecologic surgery
      • Interventions to reduce shoulder pain following gynaecological laparoscopic procedures
• PREMATURE OVARIAN FAILURE (0)
• EVALUATION OF MEASURES AIMED AT THE PREVENTION OF SUBFERTILITY (0)
• EVALUATION OF DIAGNOSTIC TECHNIQUES IN THE INVESTIGATION OR ASSESSMENT OF THE SUBFERTILE COUPLE (6)
  • METHOD OF TESTING (6)
    • Blood biomarkers for the non-invasive diagnosis of endometriosis
    • Combination of the non-invasive tests for the diagnosis of endometriosis
    • Day 5 versus day 3 embryo biopsy for preimplantation genetic testing for monogenic/single gene defects
    • Endometrial biomarkers for the non-invasive diagnosis of endometriosis
    • Imaging modalities for the non-invasive diagnosis of endometriosis
    • Urinary biomarkers for the non-invasive diagnosis of endometriosis
• EVALUATION OF SUBFERTILITY TREATMENTS RELATING TO THE FEMALE PARTNER (129)
  • OLIGO/ANOVULATION. OVULATION INDUCTION BY MEANS OF (3)
    • Medical therapies (3)
      • Aromatase inhibitors (1)
        • Aromatase inhibitors (letrozole) for ovulation induction in infertile women with polycystic ovary syndrome
      • Weight adjustment (0)
      • Anti oestrogens (clomiphene/tamoxifen/cyclophenyl) (1)
        • Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation
      • GnRHas and gonadotrophins (1)
        • Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
      • Gonadotrophins (various preparations, regimes and modalities of administration) (0)
  • SUBFERTILITY ASSOCIATED WITH ENDOMETRIOSIS (5)
    • Medical therapies (1)
      • Danazol (1)
        • Ovulation suppression for endometriosis for women with subfertility
      • GnRH agonists (0)
      • Progestins (0)
    • Surgery (open and laparoscopic) (0)
    • Assisted conception techniques (3)
      • Interventions for women with endometrioma prior to assisted reproductive technology
      • Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis
      • Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis
    • Overview (1)
      • Endometriosis: an overview of Cochrane Reviews
  • UNEXPLAINED SUBFERTILITY (15)
    • Medical therapies (6)
      • Danazol (1)
        • Danazol for unexplained subfertility
      • Bromocriptine (0)
      • Clomiphene (1)
        • Clomiphene citrate for unexplained subfertility in women
      • Gonadotrophins (1)
        • Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction
      • Combinations of the above (1)
        • Oral versus injectable ovulation induction agents for unexplained subfertility
      • Other (2)
        • Aspirin for in vitro fertilisation
        • Heparin for assisted reproduction
    • Assisted conception techniques (9)
      • Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
      • Double versus single intrauterine insemination (IUI) in stimulated cycles for subfertile couples
      • In vitro fertilisation for unexplained subfertility
      • Post-embryo transfer interventions for assisted reproduction technology cycles
      • Intra-uterine insemination for unexplained subfertility
      • Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
      • Ovulation triggers in anovulatory women undergoing ovulation induction
      • Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse
      • Agents for ovarian stimulation for intrauterine insemination (IUI) in ovulatory women with infertility
  • INFERTILITY ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME (10)
    • Medical therapies (9)
      • Clomiphene (1)
        • Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome
      • Bromocriptine (0)
      • Steroids (0)
      • Gonadotrophins (hMG and FSH) (1)
        • Which gonadotropins are the best choice to stimulate ovulation in women with polycystic ovary syndrome (PCOS)Updated
      • GnRH-agonists and gonadotrophins (1)
        • Which gonadotropins are the best choice to stimulate ovulation in women with polycystic ovary syndrome (PCOS)Updated
      • Pulsatile LHRH (1)
        • Pulsatile gonadotrophin releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome
      • Insulin sensitising agents (5)
        • Inositol for subfertile women with polycystic ovary syndrome
        • Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
        • Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome
        • Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome
        • Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
    • Surgery (1)
      • Wedge resection (0)
      • Laparoscopic ovarian "drilling" (1)
        • Laparoscopic ovarian drilling for ovulation induction in women with anovulatory polycystic ovary syndrome
  • MECHANICAL INFERTILITY (TUBAL BLOCKAGE, PELVIC ADHESIONS) (10)
    • Medical therapies (0)
    • Surgery (10)
      • Tubal flushing (1)
        • Tubal flushing for subfertility
      • Techniques of tubal surgery (5)
        • In vitro fertilisation versus tubal reanastomosis (sterilisation reversal) for subfertility after tubal sterilisation
        • Minimally invasive versus open surgery for reversal of tubal sterilization
        • Surgery for tubal infertility
        • Surgical treatment for tubal disease in women due to undergo in vitro fertilisation
        • Techniques for pelvic surgery in subfertility
      • Adjuvant peri-operative therapy to prevent adhesion (re)formation (2)
        • Barrier agents for adhesion prevention after gynaecological surgery
        • Fluid and pharmacological agents for adhesion prevention after gynaecological surgery
      • Post-operative procedures to prevent adhesion (re) formation (2)
        • Adhesion prevention agents for gynaecological surgery: an overview of Cochrane reviews
        • Postoperative procedures for improving fertility following pelvic reproductive surgery
  • SUBFERTILITY ASSOCIATED WITH FIBROIDS (2)
    • Overview (1)
      • Interventions for uterine fibroids: an overview of Cochrane Reviews
    • Surgery (1)
      • Surgical treatment of fibroids for subfertility
  • ASSISTED CONCEPTION TECHNIQUES (58)
    • Procedures (non-surgical) (55)
      • Culture media or oocytes and/or embryos (17)
        • Assisted hatching on assisted conception (in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI))
        • Brief co-incubation of sperm and oocytes for in vitro fertilization techniques
        • Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection
        • Oxytocin antagonists for assisted reproduction
        • Endometrial injection of embryo culture supernatant for subfertile women in assisted reproduction
        • Follicular flushing during oocyte retrieval in assisted reproductive techniques
        • Fresh versus frozen embryo transfers in assisted reproduction
        • GM-CSF (granulocyte macrophage colony-stimulating factor) supplementation in culture media for women undergoing assisted reproduction
        • Hyaluronic acid in embryo transfer media for assisted reproductive technologies
        • Low oxygen concentrations for embryo culture in assisted reproductive technologies
        • Number of embryos for transfer following in vitro fertilisation or intra-cytoplasmic sperm injection
        • Pain relief for women undergoing oocyte retrieval for assisted reproduction
        • Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation
        • Slow freeze versus vitrification for embryo cryopreservation
        • Temperature of embryo culture for assisted reproduction
        • Ultrasound versus 'clinical touch' for catheter guidance during embryo transfer in women
        • Cleavage-stage versus blastocyst-stage embryo transfer in assisted reproductive technology
      • Luteal support (hCG; progesterone) (1)
        • Luteal phase support for assisted reproduction cycles
      • Technique modalities (IVF, GIFT, ZIFT) (11)
        • Assisted reproductive technology: an overview of Cochrane Reviews
        • Growth hormone for in vitro fertilisation (IVF)
        • Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI)
        • Immune therapies for women with history of failed implantation undergoing IVF treatment
        • Interventions for 'poor responders' to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF)
        • Metabolomics for improving pregnancy outcomes in women undergoing assisted reproductive technologies
        • Soft versus firm catheters for intrauterine insemination
        • Soft versus firm embryo transfer catheters for assisted reproductive technology
        • Techniques for preparation prior to embryo transfer
        • What is the best therapy for women who produce too many eggs when having fertility treatment?
        • Synchronised approach for intrauterine insemination in subfertile couples
      • Ovarian stimulation protocols (drug regimes and modalities) (17)
        • Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome
        • Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis
        • Embryo freezing for preventing ovarian hyperstimulation syndrome
        • Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI
        • Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles
        • Gonadotrophin-releasing hormone antagonists for assisted reproductive technology
        • Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology
        • Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation
        • Interventions for fertility preservation in women with cancer undergoing chemotherapy
        • Volume expanders for the prevention of ovarian hyperstimulation syndrome
        • Long-acting FSH versus daily FSH for women undergoing assisted reproduction
        • Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI)
        • Natural cycle in vitro fertilisation (IVF) for subfertile couples
        • Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques
        • Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles
        • Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles
        • Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles
      • Embryo cryopreservation (2)
        • Tamoxifen or letrozole versus standard methods for women with estrogen-receptor positive breast cancer undergoing oocyte or embryo cryopreservation in assisted reproduction
        • Vitrification versus slow freezing for women undergoing oocyte cryopreservation
      • Endometrial preparation (7)
        • Vasodilators for women undergoing fertility treatmentUpdated
        • Cycle regimens for frozen-thawed embryo transfer
        • Endometrial injury in women undergoing in vitro fertilisation (IVF)
        • Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes
        • Endometrial injury for pregnancy following sexual intercourse or intrauterine insemination
        • Peri-implantation glucocorticoid administration for assisted reproductive technology cycles
        • Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer)
    • Surgery (3)
      • Methods of oocyte retrieval (0)
      • Methods of sperm preparation and oocyte insemination (2)
        • Oocyte activation for women following intracytoplasmic sperm injection (ICSI)
        • Regular (ICSI) versus ultra-high magnification (IMSI) sperm selection for assisted reproduction
      • Methods of embryo transfer (0)
      • Tubal surgery (1)
        • Pain relief in hysterosalpingography
  • SPERM-MUCOUS INTERACTION IMPAIRMENT; "CERVICAL" INFERTILITY (1)
    • Medical therapies (1)
      • Mucous enhancing treatments (0)
      • Artificial insemination by husband's sperm (AIH) (1)
        • Intra-uterine insemination versus timed intercourse or expectant management for cervical hostility in subfertile couples
      • Other (0)
  • INFERTILITY TREATMENT FOR PREMATURE OVARIAN FAILURE (0)
  • ECTOPIC PREGNANCY (2)
    • Chinese herbal medicine in the treatment of ectopic pregnancy
    • Interventions for tubal ectopic pregnancy
  • OTHER (23)
    • Acupuncture and assisted reproductive technology
    • Acupuncture for polycystic ovarian syndrome
    • Antibiotics prior to or at the time of embryo transfer in ART
    • Autologous platelet-rich plasma for assisted reproduction
    • Culture media for human pre-implantation embryos in assisted reproductive technology cycles
    • Pharmacological and non-pharmacological strategies for obese women with subfertility
    • Preconception lifestyle advice for people with infertility
    • Endometrial injury in women undergoing in vitro fertilisation (IVF)
    • Interventions for improving reproductive outcomes in women with recurrent implantation failure undergoing assisted reproductive techniques
    • Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews
    • Interventions for unexplained infertility: a systematic review and network meta-analysis
    • Nonsteroidal anti-inflammatory drugs for assisted reproductive technology
    • Ovarian cyst aspiration prior to in vitro fertilization treatment for subfertility
    • Progestogens for prevention of luteinising hormone (LH) surge in women undergoing controlled ovarian hyperstimulation as part of an assisted reproductive technology (ART) cycle
    • Psychological and educational interventions for subfertile men and women
    • Surgical intervention versus expectant management for endometrial polyps in subfertile women
    • Septum resection for women of reproductive age with a septate uterus
    • Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction
    • Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism
    • Time-lapse systems for embryo incubation and assessment in assisted reproduction
    • Timed intercourse for couples trying to conceive
    • Granulocyte-colony stimulating factor administration for subfertile women undergoing assisted reproduction
    • Vitamins and minerals for subfertility in women
• EVALUATION OF SUBFERTILITY TREATMENTS RELATING TO THE MALE PARTNER (10)
  • IDIOPATHIC OLIGO- ASTHENO- TERATOSPERMIA (1)
    • Medical therapies (1)
      • Antioestrogens (0)
      • Androgens (0)
      • Bromocriptine (0)
      • Kinin- enhancing drugs (kallikrein) (0)
      • Other medical treatments (1)
        • Gonadotrophins for idiopathic male factor subfertility
      • Artificial insemination by husband (AIH) (0)
      • Assisted conception techniques (0)
  • OLIGOSPERMIA ASSOCIATED WITH VARICOCELE (1)
    • Medical therapies (0)
    • Surgery (1)
      • "Curative" varicocele treatment (1)
        • Surgical or radiological treatment for varicoceles in subfertile men
      • Preventative varicocele treatment (0)
  • ARTIFICIAL INSEMINATION BY DONOR (DI) (1)
    • Type of semen used (fresh or frozen) (0)
    • Site of insemination (intracervical or intrauterine) (1)
      • Intrauterine insemination versus intracervical insemination in donor sperm treatment
    • Timing and number of inseminations (0)
    • Cryopreservation methods (0)
  • INFERTILITY ASSOCIATED WITH ANTISPERM ANTIBODIES (0)
    • Medical therapies (0)
      • Immuno modulating drugs (including steroids) (0)
      • Treatment of antibody containing sperm samples (0)
      • Artificial insemination (0)
      • Assisted conception techniques (0)
  • IMPOTENCE (0)
    • Medical therapies (0)
    • Psychological interventions (0)
  • HYPOGONADOTROPIC HYPOGONADISM (0)
    • Weight adjustment (0)
    • Psychological interventions (0)
    • Drug treatment (0)
  • ASSISTED CONCEPTION TECHNIQUES FOR MALE INFERTILITY (6)
    • Sperm preparation techniques (1)
      • Semen preparation techniques for intrauterine insemination
    • Micro manipulation techniques (1)
      • Intracytoplasmic sperm injection versus conventional in vitro fertilisation in couples with males presenting with normal total sperm count and motility
    • Intrauterine insemination (2)
      • Double versus single intrauterine insemination (IUI) in stimulated cycles for subfertile couples
      • Assisted reproductive technologies for male subfertility
    • Sperm Retrieval Techniques (2)
      • Advanced sperm selection techniques for assisted reproduction
      • Techniques for surgical retrieval of sperm prior to intra-cytoplasmic sperm injection (ICSI) for azoospermia
  • OTHER (1)
    • Antioxidants for male subfertility
• Surgical management of pelvic organ prolapse (6)
  • Perioperative interventions in pelvic organ prolapse surgery
  • Transvaginal mesh or grafts or native tissue repair for vaginal prolapse
  • Surgery for women with pelvic organ prolapse with or without stress urinary incontinence
  • Surgery for women with anterior compartment prolapse
  • Surgery for women with posterior compartment prolapse
  • Surgery for women with apical vaginal prolapse